rosis (4, 5) . There have been many reports that consumption of polyunsaturated fatty acids (PUFA) leads to improvement of hyperlipidemia and prevention of arteriosclerosis (6, 7) . However, there have been a few reports of an association between blood saturated fatty acid concentrations or unsaturated fatty acid concentrations and insulin resistance. In present study, we measured the serum fatty acid concentrations in patients with type 2 diabetes mellitus and investigated the relations between the homeostasis model insulin resistance index, HOMA-R (8) , and the serum fatty acid concentrations. Early morning fasting blood specimens were collected from 93 outpatients (70 men and 23 women) attending the outpatient clinic of Aichi Medical University Hospital, and their serum fatty acid concentrations were measured. Their serum insulin concentration was measured at the same time, and the correlations between serum fatty acid concentrations and HOMA-R were calculated.
SUBJECTS AND METHODS

Study Population
The study was conducted on 93 type 2 diabetes mellitus patients (70 men and 23 women, mean age 54 (SD 11) years old, body mass index 23.3 (SD 4.8)) attending the outpatient clinic for the treatment of diabetes at the Aichi Medical University Hospital. They were treated with hypoglycemic agents (pioglitazone, sulfonylurea, or α-glucosidase inhibitor) and dietetic therapy or both for 2-3 years.
Morning blood samples were collected after a 12-hour fast. The serum was separated from the blood within 1 hour, and serum samples were used to measure the concentrations of glucose, insulin, and fatty acids. All procedures were performed at 4! !or on ice water.
Informed consent was obtained from all the subjects, and the study protocol was approved by the ethics committee.
Serum glucose and insulin analysis
Serum glucose was determined by conventional enzymatic methods at SRL Inc. (Tokyo, Japan). Serum insulin was determined by a conventional enzyme immunoassay with the Glazyme insulin-EIA test (Wako Pure Chemical Industries) at SRL Inc.
Serum fatty acids
Approximately 0.2 ml of serum samples and 2 ml of chloroform-methanol (2 : 1) solution were placed in Pyrex centrifuge tubes, homogenized with a Polytron (PCU-2-110, KINEMATICA GmbH, Switzerland), and then centrifuged at 3000 rpm for 10 min. An aliquot of the chloroform-methanol extract was transferred to another Pyrex tube and dried under a stream of nitrogen gas. The dried specimens were dissolved in 100 μl 0.4M potassium methoxidemethanol/14% boron trifluoride-methanol solution, and the fatty acid concentrations in the solution were measured with a gas chromatograph (Shimazu GC 17A, Kyoto, Japan) at SRL Inc.
Statistical analysis
The correlation analysis was performed by Spearman's test. P values less than 0.05 were considered significant.
RESULTS
The fasting serum glucose levels in the diabetic patients were 135!43 mg/dl, insulin levels were 8.61!8.05 μU/ml, and HOMA-R were 2.91!2.75.
The fasting serum FFA levels are shown in Table 1 .
Regarding the fasting serum glucose, insulin, HOMA-R, and FFA levels, no sex difference was noted.
The correlations between serum SFA concentrations and HOMA-R are shown in Table 2 . The SFA that were positively correlated with HOMA-R were lauric acid (C12 : 0), myristic acid (C14 : 0), palmitic acid (C16 : 0), and stearic acid (C18 : 0). No correlations were found with regard to arachidic acid (C 20 : 0), behenic acid (C22 : 0), and lignoceric acid (C24 : 0).
The correlations between the serum MUFA concentrations and HOMA-R are shown in Table 3 . The MUFA that were positively correlated with HOMA-R were palmitoleic acid (C16 : 1), oleic acid (C18 : 1), and erucic acid (C22 : 1). No correlations were found with regard to eicosanoic acid (C20 : 1) and nervonic acid (C24 : 1).
The correlations between the PUFA serum concentration and HOMA-R are shown in Table 4 . The PUFA that were positively correlated with HOMA-R were eicosadienoic acid (C20 : 2), dihomo-γ-linolenic acid (C20 : 3), docosatetraenoic acid (C22 : 4), and docosapentaenoic acid (C22 : 5). No correlations were found with regard to linoleic acid (C18 : 2), γ-linolenic acid (C18 : 3), linolenic acid (C18 : 3), 5-8-11 eicosatrienoic acid (C20 : 3), arachidonic acid (C20 : 4), eicosapentaenoic acid (C20 : 5), and docosahexaenoic acid (C22 : 6).
DISCUSSION
Consumption of SFA induces hyperlipidemia, causing progression of arteriosclerosis (4, 5) . However, there have been many reports that consumption of PUFA leads to improvement of hyperlipidemia and prevention of arteriosclerosis (6, 7), In human (6, 7) and animal studies, a hyperlipidemiaameliorating action and cardiovascular disease preventing action have also been found to result from intake of omega-3 fatty acids (9, 10) . On the other hand, there have been few reports on the relation between fatty acid intake and glucose metabolism or insulin resistance in diabetics, and there have also been few reports describing an association between blood SFA or unsaturated fatty acid concentrations and insulin resistance.
In an animal study, Storlien LH, et al. fed rats saturated fatty acids and reported that when they fed the rats food containing omega-3 fatty acids after inducing insulin resistance, the insulin resistance improved (11) . In the present study, we measured the serum fatty acid concentrations of diabetic patients and investigated the relation between an index of insulin resistance, HOMA-R, and serum fatty acid concentrations.
In the present study, we predicted that there would be a positive correlation between serum SFA concentrations and HOMA-R and there would be a negative correlation between the serum concentrations of PUFA and HOMA-R. More specifically, we predicted that the serum concentrations of PUFA in patients with mild insulin resistance would be higher than those of patients with severe insulin resistance and that their serum concentrations of SFA would be low. The results showed positive correlations between HOMA-R and the concentrations of the SFA, i.e., lauric acid (C12), myristic acid (C14), palmitic acid (C16), and stearic acid (C18), but no correlations with arachidic acid (C20), behenic acid (C22), or lignoceric acid (C24). These results suggest that the concentrations of SFA containing a short carbon atom chain (C12-C18) are more positively correlated with HOMA-R than the concentrations of SFA with a long carbon atom chain (C20-C24), and that the severity of insulin resistance is related to a short carbon chain.
With regard to the MUFA, the concentrations of palmitoleic acid (C16 : 1), oleic acid (C18 : 1), and erucic acid (C22 : 1) were positively correlated with HOMA-R, but no correlations were observed with eicosanoic acid (C20 : 1) or nervonic acid (C24 : 1). No associations were found between the carbon chain length of MUFA and HOMA-R.
Kusunoki, et al. administered omega-3 fatty acids to OLETF rats, an animal model of diabetes, and reported that they improved their insulin resistance (12) . There are reports on omega-3 fatty acids as representative PUFA, stating that intake of PUFA improves hyperlipidemia in diabetics and prevents the progression of arteriosclerosis (13) (14) (15) . Therefore, negative correlations were predicted between the concentrations of PUFA and HOMA-R. However, none of the PUFA were found to be negatively correlated with HOMA-R in this study. In contrast, positive correlations were found with eicosadienoic acid (C20 : 2, ω6), dihomo-γ-linolenic acid (C20 : 3, ω6), docosapentaenoic acid (C20 : 5, ω3), and docosatetraenoic acid (C22 : 4, ω6), but no correlations were found between HOMA-R and following seven fatty acids, linoleic acid (C18 : 2, ω6), γ-linolenic acid (C 18 : 3, ω6), linolenic acid (C18 : 3, ω3), 5-8-11 eicosatrienoic acid (C20 : 3, ω9), arachidonic acid (C 20 : 4, ω6), eicosapenataenoic acid (C20 : 5, ω3), or docosahexaenoic acid (C22 : 6, ω3). No correlations were found between the carbon chain length of PUFA and HOMA-R, and no associations were found between HOMA-R and the ω3 fatty acids or ω6 fatty acids.
